R Squared LTD Adaptive Biotechnologies Corp Transaction History
R Squared LTD
- $103 Billion
- Q4 2024
A detailed history of R Squared LTD transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, R Squared LTD holds 890 shares of ADPT stock, worth $7,128. This represents 0.01% of its overall portfolio holdings.
Number of Shares
890Holding current value
$7,128% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding ADPT
# of Institutions
205Shares Held
146MCall Options Held
68.8KPut Options Held
42.5K-
Viking Global Investors LP30MShares$240 Million0.59% of portfolio
-
Rubric Capital Management LP New York, NY14.4MShares$115 Million2.05% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$93.4 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl11.6MShares$92.9 Million0.56% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.6MShares$85.2 Million0.0% of portfolio
About Adaptive Biotechnologies Corp
- Ticker ADPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 142,872,992
- Market Cap $1.14B
- Description
- Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...